Supply chains, in general, are vulnerable to risks, especially regarding to traceability. In the pharmaceutical industry, it has generated facts all over the world that show the circulation of illicit medicines. Sub-Saharan Africa, India, Central, and South America, are the regions where a higher incidence is reported, with an annual increasing % of medicines being ilegal. The identification of producing economies and transit points in the Supply Chain is important for challenge the illicit market.
The traceability throughout the logistics system is a requirement in the drugs supply chains, then, it is necessary that products are correctly identified, which